Chao Wang is a registered patent agent focusing on patent prosecution in the chemistry and life science industries. Chao also advises clients on due diligence matters, including providing patentability and freedom-to-operate analysis. Chao has a wide range of technical experience in patent law that includes small molecule chemistry, bioconjugation, nanoparticle, gene delivery, diagnostic imaging, and radiopharmaceuticals.
Prior to commencing a career in patent law, Chao worked as a research scientist at the University of California San Francisco, where he focused on the development of radiopharmaceuticals for diagnosis of infectious diseases using positron emission tomography imaging. Chao was a postdoc fellow in the Department of Radiology at the University of California San Diego from 2017 to 2021, where he developed lipid and polymeric nanoparticles for use in cancer diagnosis, as well as in gene delivery. His Ph.D. thesis work focused on the synthesis of optical probes for rapid detection of enantiomers in high-throughput chiral assays.
Chao has presented his scientific work at the American Chemical Society (ACS) National Meeting and at the World Molecular Imaging Congress (WMIC). He is a joint author of a dozen of highly ranked peer-reviewed chemistry and medicine journals. He is also co-inventor of two Patent Cooperation Treaty (PCT) patent applications.
- University of California San Diego (Postdoctoral Fellow in Radiology 2021); University of Virginia (Ph.D. in Organic Chemistry 2017); Renmin University of China (B.Sc. in Chemistry 2012)
- Registered to practice before the United States Patent and Trademark Office. Not licensed to practice by the State Bar of California.
- English and Chinese (Mandarin)